Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring

Clinical trial NCT01326767 · COMPLETED

Trial details

NCT number: NCT01326767
Sponsor: Central European Society for Anticancer Drug Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2011-03-01
Primary completion: 2014-12-01
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.